RxDoctor Payments Data

Janelle Fitzgerald Kratzenberg

Psychiatric/Mental Health · Chesapeake, OHNPI 1669957569

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $40,550 of the $66,712 with a category attached, or 60.8%. 22 manufacturers reported payments, led by AbbVie at 53.2% of the total. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,712in general payments, 2019–2025

Across 370 payments — averaging $180.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$36K
  • Axsome Therapeutics, Inc.$29K
  • Otsuka America Pharmaceutical, Inc.$434
  • Lundbeck LLC$421
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$207
  • Johnson & Johnson$200
  • plus $1K from 16 others

What the payments were for

  • Consulting fees$15,00022%
  • Speaking & faculty fees$40,55061%
  • Travel & lodging$5,2258%
  • Food & beverage$5,9339%
  • Education$50%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,712 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl40$71,072
RexultiBrexpiprazole21$31,152
Vilazodone Hcl23$4,349
Aripiprazole22$2,463
Duloxetine Hcl31$664
Buspirone Hcl46$594
Bupropion XlBupropion Hcl15$468
Bupropion Hcl SrBupropion Hcl15$248
Benztropine Mesylate13$232
Fluoxetine Hcl11$217
Lamotrigine14$194
Diazepam28$155
Clonazepam11$51
Lorazepam17$41
Sertraline Hcl18$38

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$35,521$71,07240 claims
Otsuka America Pharmaceutical, Inc.Rexulti$434$31,15221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Chesapeake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →